Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Care | Research article

Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test

Authors: Fiona Scorgie, Yasmin Mohamed, David Anderson, Suzanne M. Crowe, Stanley Luchters, Matthew F. Chersich

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Accurate measurement of CD4 cell counts remains an important tenet of clinical care for people living with HIV. We assessed an instrument-free point-of-care CD4 test (VISITECT® CD4) based on a lateral flow principle, which gives visual results after 40 min. The test involves five steps and categorises CD4 counts as above or below 350 cells/μL. As one component of a performance evaluation of the test, this qualitative study explored the views of healthcare workers in a large women and children’s hospital on the acceptability and feasibility of the test.

Methods

Perspectives on the VISITECT® CD4 test were elicited through in-depth interviews with eight healthcare workers involved in the performance evaluation at an antenatal care facility in Johannesburg, South Africa. Audio recordings were transcribed in full and analysed thematically.

Results

Healthcare providers recognised the on-going relevance of CD4 testing. All eight perceived the VISITECT® CD4 test to be predominantly user-friendly, although some felt that the need for precision and optimal concentration in performing test procedures made it more challenging to use. The greatest strength of the test was perceived to be its quick turn-around of results. There were mixed views on the semi-quantitative nature of the test results and how best to integrate this test into existing health services. Participants believed that patients in this setting would likely accept the test, given their general familiarity with other point-of-care tests.

Conclusions

Overall, the VISITECT® CD4 test was acceptable to healthcare workers and those interviewed were supportive of scale-up and implementation in other antenatal care settings. Both health workers and patients will need to be oriented to the semi-quantitative nature of the test and how to interpret the results of tests.
Appendix
Available only for authorised users
Literature
1.
Waldrop G, Doherty M, Vitoria M, Ford N. Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Tropical Med Int Health. 2016;21(9):1124–30.CrossRef
2.
Fauci AS, Marston HD. Ending the HIV-AIDS pandemic--follow the science. N Engl J Med. 2015;373(23):2197–9.CrossRef
3.
WHO: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach - second edition. 2016.
4.
5.
National Department of Health. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults; 2015.
6.
National Department of Health South Africa. Implementation of the universal Test and Treat strategy for HIV positive patients and differentiated care for stable patients. 2016.
7.
WHO. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. 2017.
8.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV: Department of Health and Human Services; 2017.
9.
WHO. What’s new in treatment monitoring: viral load and CD4 testing. HIV treatment and care – information note. 2017.
10.
UNAIDS: Ending AIDS. Progress towards the 90–90-90 targets. Global AIDS update 2017: UNAIDS/JC2900E; 2017.
11.
Habiyambere V, Ford N, Low-Beer D, Nkengasong J, Sands A, Perez Gonzalez M, Fernandes P, Milgotina E. Availability and use of HIV monitoring and early infant diagnosis technologies in WHO member states in 2011-2013: analysis of annual surveys at the facility level. PLoS Med. 2016;13(8):e1002088.CrossRef
12.
Drain PK, Hyle EP, Noubary F, Freedberg KA, Wilson D, Bishai WR, Rodriguez W, Bassett IV. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014;14(3):239–49.CrossRef
13.
Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, Lu Z, Losina E, Walensky RP, Freedberg KA. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009;51(2):135–9.CrossRef
14.
Drain PK, Rousseau C. Point-of-care diagnostics: extending the laboratory network to reach the last mile. Curr Opin HIV AIDS. 2017;12(2):175–81.CrossRef
15.
Vogt F, Tayler-Smith K, Bernasconi A, Makondo E, Taziwa F, Moyo B, Havazvidi L, Satyanarayana S, Manzi M, Khogali M, et al. Access to CD4 testing for rural HIV patients: findings from a cohort study in Zimbabwe. PLoS One. 2015;10(6):e0129166.CrossRef
16.
Clinton Health Access Initiative. Barriers and opportunities to scaling up HIV viral load testing. CHAI data from Mozambique, Malawi and South Africa. Data presented at AIDS conference, July 20, 2016. p. 2016.
17.
Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, Bekker LG, Hou T, Wood R, Francke JA, et al. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis. PLoS One. 2015;10(3):e0117751.CrossRef
18.
Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014;11(9):e1001725.CrossRef
19.
Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA, Buchsbaum S, Moeller G, et al. Requirements for high impact diagnostics in the developing world. Nature. 2006;444(Suppl 1):73–9.CrossRef
20.
Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, et al. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. The lancet HIV. 2016;3(11):e539–48.CrossRef
21.
Joseph J, Gotora T, Erlwanger AS, Mushavi A, Zizhou S, Masuka N, Boeke CE, Mangwiro AZ. Impact of point-of-care CD4 testing on retention in care among HIV-positive pregnant and breastfeeding women in the context of option B+ in Zimbabwe: a cluster randomized controlled trial. J Acquir Immune Defic Syndr. 2017;75(Suppl 2):S190–s197.CrossRef
22.
Stevens WS, Gous NM, MacLeod WB, Long LC, Variava E, Martinson NA, Sanne I, Osih R, Scott LE. Manuscript title: multidisciplinary point of care testing in south African primary healthcare clinics accelerates HIV ART initiation but does not alter retention in care. J Acquir Immune Defic Syndr. 2017.
23.
Daneau G, Aboud S, Prat I, Urassa W, Kestens L. Performance of FACSPresto point-of-care instrument for CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients attending care and treatment clinics in Belgium and Tanzania. PLoS One. 2017;12(1):e0170248.CrossRef
24.
Givens M, Weaver A, Bickman S, Logan C, Noormahomed EV, Patel S, Schooley RT, Benson CA, Lochhead MJ. Near patient CD4 count in a hospitalized HIV patient population. Cytometry B Clin Cytom. 2015.
25.
Makadzange AT, Bogezi C, Boyd K, Gumbo A, Mukura D, Matubu A, Ndhlovu CE. Evaluation of the FACSPresto, a new point of care device for the enumeration of CD4% and absolute CD4+ T cell counts in HIV infection. PLoS One. 2016;11(7):e0157546.CrossRef
26.
Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S. Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review. BMC Health Serv Res. 2016;16(a):343.CrossRef
27.
Fajardo E, Metcalf C, Piriou E, Gueguen M, Maman D, Chaillet P, Cox V, Rumaney MB, Tunggal S, Kosack C, et al. Errors generated by a point-of-care CD4+ T-lymphocyte analyser: a retrospective observational study in nine countries. Bull World Health Organ. 2015;93(9):623–30.CrossRef
28.
Omega Diagnostics. CD4 Count: VISITECT®. 2017.
29.
Luchters S, Technau K, Mohamed Y, Chersich MF, Agius PA, Pham MD, Garcia ML, Forbes J, Shepherd A, Coovadia A, et al. The field performance and diagnostic accuracy of a low-cost instrument-free point-of-care CD4 test (VISITECT(R) CD4) performed by different health worker cadres among pregnant women. J Clin Microbiol. 2018.
30.
Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S. Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis. BMC Infect Dis. 2016;16(1):592.CrossRef
31.
Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 2012;9(9):e1001306.CrossRef
32.
Boadu NY, Amuasi J, Ansong D, Einsiedel E, Menon D, Yanow SK. Challenges with implementing malaria rapid diagnostic tests at primary care facilities in a Ghanaian district: a qualitative study. Malar J. 2016;15:126.CrossRef
33.
Mashamba-Thompson TP, Jama NA, Sartorius B, Drain PK, Thompson RM. Implementation of point-of-care diagnostics in rural primary healthcare clinics in South Africa: perspectives of key stakeholders. Diagnostics (Basel). 2017;7:1.
34.
FDA news Device Daily Bulletin. Medical Devices: Submissions and Approvals: Omega Diagnostics HIV Test Scores CE Mark; 2017.
35.
Technau KG, Kuhn L, Coovadia A, Carmona S, Sherman G. Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges. J Int AIDS Soc. 2017, 21436;20(1).
36.
van der Merwe K, Hoffman R, Black V, Chersich M, Coovadia A, Rees H. Birth outcomes in south African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc. 2011;14:42.CrossRef
37.
van der Merwe K, Chersich MF, Technau K, Umurungi Y, Conradie F, Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr. 2006;43(5):577–81.PubMed
38.
Urban M, Chersich M. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care. S Afr Med J. 2004;94(5):362–6.PubMed
39.
Strauss A, Corbin J. Basics of qualitative research techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks: Sage Publications; 1998.
40.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
41.
Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014;17:18809.CrossRef
42.
Mashamba-Thompson TP, Drain PK, Sartorius B. Evaluating the accessibility and utility of HIV-related point-of-care diagnostics for maternal health in rural South Africa: a study protocol. BMJ Open. 2016;6(6):e011155.CrossRef
43.
Desai MA, Okal DO, Rose CE, Ndivo R, Oyaro B, Otieno FO, Williams T, Chen RT, Zeh C, Samandari T. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial. Lancet HIV. 2017;4(9):e393–401.CrossRef
44.
Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, Fox MP, Rosen S. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr. 2012;61(2):e13–7.CrossRef
45.
Gous NM, Scott LE, Potgieter J, Ntabeni L, Sanne I, Stevens WS. Implementation and operational research: implementation of multiple point-of-care testing in 2 HIV antiretroviral treatment clinics in South Africa. J Acquir Immune Defic Syndr. 2016;71(2):e34–43.CrossRef
46.
Phiri TB, Kaunda-Khangamwa BN, Bauleni A, Chimuna T, Melody D, Kalengamaliro H, Sande JH, Nsona HK, Mathanga DP. Feasibility, acceptability and impact of integrating malaria rapid diagnostic tests and pre-referral rectal artesunate into the integrated community case management programme. A pilot study in Mchinji district, Malawi. Malar J. 2016;15:177.CrossRef
47.
Zeh C, Rose CE, Inzaule S, Desai MA, Otieno F, Humwa F, Akoth B, Omolo P, Chen RT, Kebede Y, et al. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya. J Immunol Methods. 2017;448:44–50.CrossRef
48.
Daneau G, Buyze J, Wade D, Diaw PA, Dieye TN, Thai S, Florence E, Lynen L, Kestens L. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients. Cytometry B Clin Cytom. 2016.
49.
Mtapuri-Zinyowera S, Chiyaka ET, Mushayi W, Musuka G, Naluyinda-Kitabire F, Mushavi A, Chikwasha V. PIMA point of care CD4+ cell count Machines in Remote MNCH settings: lessons learned from seven districts in Zimbabwe. Infect Dis (Auckl). 2013;6:51–60.CrossRef
50.
Thakar M, Mahajan B, Shaikh N, Bagwan S, Sane S, Kabra S, Rewari B, Shaukat M, Singh N, Trevor P, et al. Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India. AIDS Res Ther. 2012;9(1):26.CrossRef
51.
Pinto IC, Sabido M, Pereira AB, Mello MB, de Melo Xavier Shimizu A, Protti BL, Benzaken AS. Field evaluation of a point-of-care CD4 analyzer for monitoring HIV patients in the interior of the Amazon region, Brazil. PloS one. 2015;10(4):e0121400.CrossRef
52.
Faal M, Naidoo N, Glencross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr. 2011;58(3):e54–9.CrossRef
53.
Ministry of Health - National AIDS & STI Control Programme. Guidelines on use of Antiretroviral Drugs for Treating and Preventing HIV Infections in Kenya - 2016 Edition. Nairobi: NASCOP; 2016.
Metadata
Title
Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test
Authors
Fiona Scorgie
Yasmin Mohamed
David Anderson
Suzanne M. Crowe
Stanley Luchters
Matthew F. Chersich
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-3948-x

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue

Research article

Adherence to standard nursing protocols on nasogastric tube feeding in a secondary referral hospital in Ghana: comparing self-ratings by professional and auxiliary nurses

Research article

A predictive model for non-completion of an intensive specialist obesity service in a public hospital: a case-control study

Research article

Evidence-based care in high- and low-risk groups following whiplash injury: a multi-centre inception cohort study

Research article

Process evaluation of a behaviour change approach to improving clinical practice for detecting hereditary cancer

Research article

Inequality in geographical distribution of hospitals and hospital beds in densely populated metropolitan cities of Iran

Research article

Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London